Showing results (91-100 of 168) with videos related to

Sort By:
Pageof 17
Journal of the American College of Cardiology|December 21, 2013
Treatment goals of pulmonary hypertensionVallerie V McLaughlin, Sean Patrick Gaine, Luke S Howard, et al.
Cardiovascular Radiation Medicine|February 22, 2005
Clinical and angiographic profile of patients with markedly elevated coronary calcium scores (>or=1000) detected by electron beam computed tomographyFrancis Q Almeda, Rima Shah, Shaun Senter, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 16, 2025
Evaluating oral selexipag in pulmonary arterial hypertension: Insights on survival, safety, and dosing patterns from the complete observation period of GRIPHON and its open-label extensionVallerie V McLaughlin, Luke Howard, Jean Elwing, et al.
Pulmonary Circulation|December 23, 2020
Assessment of the REPLACE study composite endpoint in riociguat-treated patients in the PATENT studyGérald Simonneau, Hossein-Ardeschir Ghofrani, Paul A Corris, et al.
American Journal of Respiratory and Critical Care Medicine|September 2, 2006
Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertensionVallerie V McLaughlin, Ronald J Oudiz, Adaani Frost, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 2, 2024
Changes in REVEAL Lite 2 risk status are associated with long-term outcomes in patients with pulmonary arterial hypertension: A post-hoc analysis of the GRIPHON studyRaymond L Benza, Kelly M Chin, Sean Gaine, et al.
The Lancet. Respiratory Medicine|August 23, 2021
Selonsertib in adults with pulmonary arterial hypertension (ARROW): a randomised, double-blind, placebo-controlled, phase 2 trialStephan Rosenkranz, Jeremy Feldman, Vallerie V McLaughlin, et al.
Chest|May 7, 2011
Long-term treatment with sildenafil citrate in pulmonary arterial hypertension: the SUPER-2 studyLewis J Rubin, David B Badesch, Thomas R Fleming, et al.
American Journal of Respiratory and Critical Care Medicine|June 9, 2012
Modern age pathology of pulmonary arterial hypertensionElvira Stacher, Brian B Graham, James M Hunt, et al.
Chest|September 25, 2008
Ambrisentan therapy in patients with pulmonary arterial hypertension who discontinued bosentan or sitaxsentan due to liver function test abnormalitiesMichael D McGoon, Adaani E Frost, Ronald J Oudiz, et al.
Pageof 17